![New research suggest ketogenic diets may cause an increased risk of Type 2 diabetes in the early stage of the diet. [United States Air Force]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug9_2018_KirtlandAirForceBase_KetogenicDiet_SalmonButterOliveOilCoconutSteak1801911782-218x150.jpg "Ketogenic Diet Alters Gut Microbiome Leading to Reduced Levels of Proinflammatory T Cells")
Smart AI Use Could Benefit Biopharma
Artificial intelligence has an important role in bioreactors and beyond if biopharma can work out how to use it on the factory floor.
Digital Ecosystem Combines Process Control, Analytics, and Plant-Level Automation
Bioprocessing 4.0 depends on integrated software, and MilliporeSigma just rolled out a new option.
AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment
Deal covers the production of Clevegen, a humanized anti-Clever-1 antibody.
Streamlining High-Throughput Impurity Analysis in Process Development
Sponsor: Lonza
REGISTER NOW
Broadcast Date: June 4, 2020
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
In the biopharma industry, there currently is a need to increase production capacity to meet the analytical demands of process development...
BIOPROCESSING 4.0: Advanced Monitoring Tech Trends in Production
Sponsored by: SartoriusSartorius has long been a leader in bioprocessing and its expertise is clearly on display in this e-book, specifically in the company’s adoption of advanced monitoring techniques in bioproduction. Here you will read about how Sartorius uses state-of-the art biosensors to carry out critical monitoring procedures during bioreactor operations.
Coronavirus Vaccine Race Approaching Quality Control Hurdle
COVID-19 has increased vaccine sector demand for contractors with next generation QC and formulation technologies.
Hidden Costs of Single-Use Bioprocessing Technology
Taking a close look at the pros and cons of an increasingly popular biomanufacturing methodology.
Sartorius’ Acquisition of Danaher Techs Fits Demand for Process Intensification
Industry bioprocessing needs are diversifying, and the technology acquired from Danaher is intended to close the gaps.
Univercells Launches New Bioprocess Subsidiary
Company wants to boost its market reach to support advances in cell and gene therapy manufacturing.
Genome Editing Helps Cell Lines “Clean Up” Their Protein Production
The mammalian cell lines that are engineered to produce high-value recombinant-protein drugs also produce unwanted proteins that reduce drug quality and increase production costs. Researchers have now introduced a CRISPR-Cas9 genome-editing technique that can eliminate up to 70% of the contaminating protein by mass in recombinant-protein drugs produced by CHO cells, workhorses of biotherapeutic protein production.
